Management of relapses with corticosteroids

A 28-year-old woman with known relapsing-remitting multiple sclerosis (RRMS) for 2 years was seen in the emergency room for a subacute onset of right-hemibody paresthesia and weakness. Her symptoms had started 3 days prior and were gradually worsening. She was taking an injectable disease-modifying therapy (DMT), glatiramer acetate, that was well tolerated. Her most recent brain MRI was a year ago and her lesion load was stable. She was otherwise in good general health and did not have any infectious symptoms or fever in the weeks preceding her clinical presentation. She had no systemic symptoms and had never experienced these symptoms before.